Cargando…
Efficacy of Vaccine Protection Against COVID-19 Virus Infection in Patients with Chronic Liver Diseases
The outbreak of coronavirus disease 2019 (COVID-19) has resulted in significant morbidity and mortality worldwide. Vaccination against coronavirus disease 2019 is a useful weapon to combat the virus. Patients with chronic liver diseases (CLDs), including compensated or decompensated liver cirrhosis...
Autores principales: | Cheung, Carmen Ka Man, Law, Kimmy Wan Tung, Law, Alvin Wing Hin, Law, Man Fai, Ho, Rita, Wong, Sunny Hei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037513/ https://www.ncbi.nlm.nih.gov/pubmed/36969905 http://dx.doi.org/10.14218/JCTH.2022.00339 |
Ejemplares similares
-
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era
por: Mak, Joyce Wing Yan, et al.
Publicado: (2023) -
Transfusion-transmitted hepatitis E: What we know so far?
por: Cheung, Carmen Ka Man, et al.
Publicado: (2022) -
Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases
por: Law, Man Fai, et al.
Publicado: (2021) -
(−)-Epiafzelechin Protects against Ovariectomy-induced Bone Loss in Adult Mice and Modulate Osteoblastic and Osteoclastic Functions In Vitro
por: Wong, Ka-Chun, et al.
Publicado: (2017) -
Massive pulmonary embolism in a patient with polysplenia syndrome and interrupted inferior vena cava with azygous continuation
por: Cheung, Carmen K. M., et al.
Publicado: (2017)